2nd Quarter - Amendment

BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY

Firm
Client
Income
—
Expenses
$670,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 20, 2015 $670,000 Replaced
2nd Quarter - Amendment (this page) Nov 29, 2016 $670,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

S. Con. Res. 11, budget resolution, regarding all biopharmaceutical related provisions.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: S.Con.Res. 11 (114th)

Trade (domestic/foreign) TRD

No bill, lobbied to strengthen intellectual property rights in trade agreements and international negotiations.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE

Copyright/Patent/Trademark CPT

HR 9, the Innovation Act, regarding all biopharmaceutical related provisions. S. 1137, Protecting American Talent and Entrepreneurship Act, regarding all biopharmaceutical related provisions.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Bills named: S. 1137 (114th), H.R. 9 (114th)

Health Issues HCR

Labor, HHS Appropriations,regarding all biopharmaceutical related provisions. Agriculture Appropriations, regarding all biopharmaceutical related provisions. H.R. 1078, FDA Safety Over Sequestration Act, regarding all biopharmaceutical related provisions. No bill, raised awareness about atrial fibrillation and stroke prevention. H/R. 1101, Viral Hepatitis Testing Act, regarding all biopharmaceutical related provisions. H.R.6, 21st Century Cures Initiative, regarding all biopharmaceutical related provisions.

LobbyistCovered position, as disclosed
RONALD MILLER —
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC)

Bills named: H.R. 1078 (114th), H.R. 6 (114th)

Medicare/Medicaid MMM

H.R. 1416, Cancer Patient Protection Act, regarding all biopharmaceutical related provisions. H.R. 1190 and S. 41, Protecting Seniors' Access to Medicare Act, regarding all biopharmaceutical related provisions. H.R. 2, Medicare Access and CHIP Authorization Act, regarding all biopharmaceutical related provisions H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors Act, regarding all biopharmaceutical related provisions.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS —

Contacted: SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: S. 41 (114th), H.R. 1416 (114th), H.R. 2570 (114th), H.R. 2 (114th), H.R. 1190 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.